Cooper Physician Offices, Pa - Medicare Primary Care in Camden, NJ

Cooper Physician Offices, Pa is a medicare enrolled primary clinic (Internal Medicine) in Camden, New Jersey. The current practice location for Cooper Physician Offices, Pa is 3 Cooper Plz, Suite 215, Camden, New Jersey. For appointments, you can reach them via phone at (856) 342-2439. The mailing address for Cooper Physician Offices, Pa is 1 Federal Street, Sw-200, Camden, New Jersey and phone number is (856) 356-4924.

Cooper Physician Offices, Pa is licensed to practice in New Jersey (license number ). The clinic also participates in the medicare program and its NPI number is 1154369510. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (856) 342-2439.

Contact Information

Cooper Physician Offices, Pa
3 Cooper Plz
Suite 215
Camden
NJ 08103-1438
(856) 342-2439
(856) 966-0735

Primary Care Clinic Profile

Full NameCooper Physician Offices, Pa
SpecialityInternal Medicine
Location3 Cooper Plz, Camden, New Jersey
Authorized Official Name and PositionAnthony J. Mazzarelli (CHIEF MEDICAL OFFICE)
Authorized Official Contact8569687858
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Cooper Physician Offices, Pa
1 Federal Street
Sw-200
Camden
NJ 08103-1155

Ph: (856) 356-4924
Cooper Physician Offices, Pa
3 Cooper Plz
Suite 215
Camden
NJ 08103-1438

Ph: (856) 342-2439

NPI Details:

NPI Number1154369510
Provider Enumeration Date06/04/2006
Last Update Date07/27/2016

Medicare PECOS Information:

Medicare PECOS PAC ID2860396611
Medicare Enrollment IDO20031122000067

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Medical Identifiers

Medical identifiers for Cooper Physician Offices, Pa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1154369510NPI-NPPES
0736144001OtherAMERIHEALTH
0736144029OtherAMERIHEALTH
3946789OtherAETNA - 196 GROVE AVE, THOROFARE, NJ
475767OtherAETNA - 900 CENTENNIAL BLVD., VOORHEES, NJ
0736144000OtherAMERIHEALTH
0736144012OtherAMERIHEALTH
1153819OtherAETNA - 13 TOMLINSON ., MEDFORD, NJ
115506OtherAETNA - 3 COOPER PLAZA, SUITE 215 CAMDEN, NJ
3626248OtherAETNA - 1103 N. KINGS HWY, CHERRY HILL, NJ
6223605MedicaidNJ
735993OtherAETNA - 1210 BRACE RD., CHERRY HIL, NJ
0736144003OtherAMERIHEALTH
482284OtherAETNA - 1103 NORTH KINGS HWY, CHERRY HILL, NJ
0736144002OtherAMERIHEALTH
0736144027OtherAMERIHEALTH
0736144004OtherAMERIHEALTH
0736144005OtherAMERIHEALTH
0736144013OtherAMERIHEALTH
0736144025OtherAMERIHEALTH
0736144028OtherAMERIHEALTH
288755OtherAETNA
478779OtherAETNA - 14 S BROADWAY ,GLOUCESTER, NJ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine (* (Not Available))Secondary
207R00000XInternal Medicine (New Jersey)Primary
208M00000XHospitalist (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Cooper Physician Offices, Pa acts as a billing entity for following providers:
Provider NameRajesh Malik
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1417997115
PECOS PAC ID: 8426962283
Enrollment ID: I20031117000086

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJeffrey Brenner
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1558392217
PECOS PAC ID: 3971409756
Enrollment ID: I20031211000513

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDouglas J Hanes
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1225138910
PECOS PAC ID: 2860398583
Enrollment ID: I20031211000766

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMangesh M Mungekar
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1144306069
PECOS PAC ID: 8820994544
Enrollment ID: I20031211000779

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJames Q Atkinson
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1881671444
PECOS PAC ID: 2668373309
Enrollment ID: I20040116000100

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJeffrey Alken
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1861472342
PECOS PAC ID: 2668369737
Enrollment ID: I20040303001069

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMark Angelo
Provider TypePractitioner - Hospice/palliative Care
Provider IdentifiersNPI Number: 1144319682
PECOS PAC ID: 0244225530
Enrollment ID: I20040416000605

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDavid R Gerber
Provider TypePractitioner - Critical Care (intensivists)
Provider IdentifiersNPI Number: 1861580219
PECOS PAC ID: 8224025226
Enrollment ID: I20040430000166

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDarryl B Floyd
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1689676421
PECOS PAC ID: 1759371750
Enrollment ID: I20040513000083

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMarianne T Alexander
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1598731424
PECOS PAC ID: 8224011689
Enrollment ID: I20040608001072

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAshoke K Deb
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1124088760
PECOS PAC ID: 7719967173
Enrollment ID: I20040726000075

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAkshay S Dave
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1770563074
PECOS PAC ID: 7113997719
Enrollment ID: I20040730000064

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameEric Kupersmith
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1831271261
PECOS PAC ID: 4981676947
Enrollment ID: I20040810000832

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGlenn C Newell
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1841390150
PECOS PAC ID: 8820060809
Enrollment ID: I20040810000962

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSteven T Nguy
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1336249523
PECOS PAC ID: 7911979901
Enrollment ID: I20040810001053

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMeena R Sharma
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1992801237
PECOS PAC ID: 1759353758
Enrollment ID: I20040810001126

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSanjay Misra
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1528096948
PECOS PAC ID: 0840268983
Enrollment ID: I20040917000149

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameManish A Patel
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1326019175
PECOS PAC ID: 7911975412
Enrollment ID: I20040922000790

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePrathibha Potharlanka
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1295761690
PECOS PAC ID: 4587633862
Enrollment ID: I20041004000017

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDeepa N Velayadikot
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1437176880
PECOS PAC ID: 1850354333
Enrollment ID: I20041105000383

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameInciya Rangwalla-malickel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1952491250
PECOS PAC ID: 9830153873
Enrollment ID: I20041118000557

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAsma Ahmed
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1225023682
PECOS PAC ID: 3678525912
Enrollment ID: I20050215000956

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAnuradha L Mookerjee
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1902982820
PECOS PAC ID: 8527011998
Enrollment ID: I20050225000043

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMark A Thomas
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1043391618
PECOS PAC ID: 2961392493
Enrollment ID: I20050302000598

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAhsan A Abdulghani
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1881670891
PECOS PAC ID: 7517939432
Enrollment ID: I20050303000061

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRosemarie A Leuzzi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1861574220
PECOS PAC ID: 2860442951
Enrollment ID: I20050405000043

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAnjali A Desai
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1225137797
PECOS PAC ID: 8921046855
Enrollment ID: I20050421000448

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePaul A Stone
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1932101664
PECOS PAC ID: 4688613896
Enrollment ID: I20050427000929

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameXiaodan Ye
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1700802212
PECOS PAC ID: 3476593351
Enrollment ID: I20050510000861

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGrace S Cho
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1730390717
PECOS PAC ID: 6901841998
Enrollment ID: I20050621000372

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameVijaykumar K Rajput
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1588754881
PECOS PAC ID: 2062457054
Enrollment ID: I20050621000398

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNancy H Beggs
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1407945272
PECOS PAC ID: 3971548561
Enrollment ID: I20050623000828

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDavid D Gross
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1538130398
PECOS PAC ID: 9830143932
Enrollment ID: I20050712000548

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJohn A Kirby
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1164502126
PECOS PAC ID: 7810923760
Enrollment ID: I20050712000588

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNaeem M Amin
Provider TypePractitioner - Nephrology
Provider IdentifiersNPI Number: 1659326833
PECOS PAC ID: 9638169618
Enrollment ID: I20050726000377

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKatherine Ann Penberthy
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1255420667
PECOS PAC ID: 4587692553
Enrollment ID: I20050808000427

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAlyssa R Angelino
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1861602070
PECOS PAC ID: 1153358841
Enrollment ID: I20050913000433

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAney M Abraham
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1275637720
PECOS PAC ID: 7315994811
Enrollment ID: I20050926000733

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameHazel A Nurse
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1619190089
PECOS PAC ID: 7618902131
Enrollment ID: I20051003000750

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJanel L Roseberry
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1225173461
PECOS PAC ID: 8527093210
Enrollment ID: I20051004000754

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameVedam Gummadi
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1427253624
PECOS PAC ID: 0042245474
Enrollment ID: I20051004000795

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAnthony Md Sherman
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1235235524
PECOS PAC ID: 0244255289
Enrollment ID: I20051010000490

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePhilip M George
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1851472070
PECOS PAC ID: 4789602756
Enrollment ID: I20051108000719

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameFateen Zafar
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1811080641
PECOS PAC ID: 7416848676
Enrollment ID: I20051115000007

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameHerbert C Conaway
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1649387283
PECOS PAC ID: 0840213377
Enrollment ID: I20060110000928

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDaniel J Hyman
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1346335023
PECOS PAC ID: 2769405273
Enrollment ID: I20060111000356

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAlan Greenberg
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1326092180
PECOS PAC ID: 0345263851
Enrollment ID: I20060111000397

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAliya W Khan
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1366473654
PECOS PAC ID: 5395769673
Enrollment ID: I20060125000822

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameEsteban F Troyanovich
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1679590020
PECOS PAC ID: 9335154731
Enrollment ID: I20060207000067

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMary J Monari-sparks
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1356324263
PECOS PAC ID: 3173530961
Enrollment ID: I20060320000704

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJuan S Utreras
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1518906270
PECOS PAC ID: 4082622287
Enrollment ID: I20060330000045

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDorrie Susan A Barrington
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1184679557
PECOS PAC ID: 7214834217
Enrollment ID: I20060810000404

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRaymond J Logue
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1376564716
PECOS PAC ID: 3173520764
Enrollment ID: I20061024000199

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAbu M Ahsan
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1316994437
PECOS PAC ID: 0648278457
Enrollment ID: I20061109000524

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameChristina V Orate Dimapilis
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1508831330
PECOS PAC ID: 0941208565
Enrollment ID: I20061115000083

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAmi Sharad Joshi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1710900865
PECOS PAC ID: 6800836685
Enrollment ID: I20061116000036

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBrian P Gable
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1336244672
PECOS PAC ID: 1658370531
Enrollment ID: I20061205000028

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRania H Loutfi
Provider TypePractitioner - Hospice/palliative Care
Provider IdentifiersNPI Number: 1265443618
PECOS PAC ID: 1153321195
Enrollment ID: I20061222000111

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAdarsh Arya
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1457323008
PECOS PAC ID: 8527035930
Enrollment ID: I20070111000082

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRocco F Caveng
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1780603381
PECOS PAC ID: 9234231200
Enrollment ID: I20070313000172

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSusan C Coutinho Mcallister
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1932120375
PECOS PAC ID: 8224134598
Enrollment ID: I20070502000511

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKelly L Gilrain
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1669580395
PECOS PAC ID: 2163529504
Enrollment ID: I20070521000237

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSaadia Raza Rehman
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1316921414
PECOS PAC ID: 5294728853
Enrollment ID: I20070703000214

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKennedy U Ganti
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1235322165
PECOS PAC ID: 0547356149
Enrollment ID: I20071012000043

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSnehal V Gandhi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1760509533
PECOS PAC ID: 0446346837
Enrollment ID: I20071017000103

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBehjath Jafry
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1043402456
PECOS PAC ID: 6608962501
Enrollment ID: I20071023000212

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGayatri Borra
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1972676112
PECOS PAC ID: 5496842015
Enrollment ID: I20071030000130

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameTudor J Vlad
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1740469485
PECOS PAC ID: 5597847988
Enrollment ID: I20080124000022

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNidhi Agrawal
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1245246982
PECOS PAC ID: 7113000852
Enrollment ID: I20080219000023

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameElaine C Paynter
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1780884080
PECOS PAC ID: 5496839797
Enrollment ID: I20080226000235

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNimra H Rana
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1831392422
PECOS PAC ID: 7416032503
Enrollment ID: I20080313000397

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameThilagavathi Venkatachalam
Provider TypePractitioner - Nephrology
Provider IdentifiersNPI Number: 1124213442
PECOS PAC ID: 7315023751
Enrollment ID: I20080325000478

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameEdward D Viner
Provider TypePractitioner - Hematology/oncology
Provider IdentifiersNPI Number: 1609957026
PECOS PAC ID: 0143126573
Enrollment ID: I20080408000022

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameIrina Levin
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1477749182
PECOS PAC ID: 0244318715
Enrollment ID: I20080424000006

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMary Elizabeth Gaskill
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1427235928
PECOS PAC ID: 3072691583
Enrollment ID: I20080424000358

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJaymica Patel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1235306952
PECOS PAC ID: 6406928118
Enrollment ID: I20080711000243

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMaria E Lauer-pfrommer
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1831358639
PECOS PAC ID: 1951476696
Enrollment ID: I20080815000003

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCatherine M Gerety
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1144425554
PECOS PAC ID: 0648338632
Enrollment ID: I20081020000493

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameElizabeth A Cerceo
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1902969561
PECOS PAC ID: 7214095892
Enrollment ID: I20081027000229

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGita S Ponnappan
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1699972398
PECOS PAC ID: 3274691639
Enrollment ID: I20081029000385

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRonald Schiavone
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1225075096
PECOS PAC ID: 9638230477
Enrollment ID: I20081211000362

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSatyajeet Roy
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1437116829
PECOS PAC ID: 8527129246
Enrollment ID: I20081212000254

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMahbubur R Siddique
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1013168467
PECOS PAC ID: 7113089780
Enrollment ID: I20081217000055

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePalanipriya Kalyan
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1154570703
PECOS PAC ID: 7517029960
Enrollment ID: I20081219000189

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGary Xavier Heck
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1316984180
PECOS PAC ID: 4688737620
Enrollment ID: I20090116000344

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePaul P Mcmackin
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1720249428
PECOS PAC ID: 7113083593
Enrollment ID: I20090310000404

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAlka Rajesh Farmer
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1821207143
PECOS PAC ID: 4082764618
Enrollment ID: I20090602000583

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNami Kim
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1366633612
PECOS PAC ID: 1759458847
Enrollment ID: I20090721000698

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameStephanie M Tonetta-stanker
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1588735963
PECOS PAC ID: 3678627619
Enrollment ID: I20090811000130

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKara S Aplin
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1124063771
PECOS PAC ID: 9133122039
Enrollment ID: I20090814000569

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRitesh B Patel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1356575120
PECOS PAC ID: 1052465630
Enrollment ID: I20090817000317

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNinon Matos
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1174757256
PECOS PAC ID: 2264586577
Enrollment ID: I20090821000138

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMonica Atkinson
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1447405972
PECOS PAC ID: 0244385086
Enrollment ID: I20090901000062

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJennifer A Clark
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1629203948
PECOS PAC ID: 4789720301
Enrollment ID: I20091012000278

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMichael R Malone
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1194916908
PECOS PAC ID: 8123165123
Enrollment ID: I20091023000352

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSherry Singh Mohapatra
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1528020062
PECOS PAC ID: 6406743608
Enrollment ID: I20091221000014

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDavid Lewis Shklar
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1124040407
PECOS PAC ID: 7012985039
Enrollment ID: I20091223000381

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDan Dragomir
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1427071091
PECOS PAC ID: 8628075041
Enrollment ID: I20100201000568

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameChristopher Bolich
Provider TypePractitioner - Hospice/palliative Care
Provider IdentifiersNPI Number: 1861592347
PECOS PAC ID: 7416091988
Enrollment ID: I20100222000525

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJeffrey Howard Millstein
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1396772281
PECOS PAC ID: 5991831968
Enrollment ID: I20100329000921

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRosemarie Stag
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1447588611
PECOS PAC ID: 9234265752
Enrollment ID: I20100409000025

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAshley J Coleman
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1306009709
PECOS PAC ID: 1557499225
Enrollment ID: I20100518000046

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRavi Chhabra
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1881893030
PECOS PAC ID: 4082769211
Enrollment ID: I20100603000747

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKimberly I Rozengarten
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1801087671
PECOS PAC ID: 3971635418
Enrollment ID: I20100719000310

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAllan J. Falescky
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1427161777
PECOS PAC ID: 6901947068
Enrollment ID: I20100826000270

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJean-sebastien K Rachoin
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1174796213
PECOS PAC ID: 6608991401
Enrollment ID: I20100916001266

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameOlga M Schweiker
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1437396280
PECOS PAC ID: 4486770724
Enrollment ID: I20100924000016

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJoseph G Gambale
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1851599120
PECOS PAC ID: 2668598855
Enrollment ID: I20100924000820

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMartin Scott Dawson
Provider TypePractitioner - Cardiovascular Disease (cardiology)
Provider IdentifiersNPI Number: 1609815836
PECOS PAC ID: 4688685126
Enrollment ID: I20101026000917

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNiranjan Patel
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1043487978
PECOS PAC ID: 0648318873
Enrollment ID: I20101118000034

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMaxim V Sungurov
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1952397812
PECOS PAC ID: 3375432099
Enrollment ID: I20101123000030

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameFrancis Lopes
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1144318858
PECOS PAC ID: 0648468942
Enrollment ID: I20110103000155

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameVincent A Renzi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1760428494
PECOS PAC ID: 7810904877
Enrollment ID: I20110110000027

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAnna Headly
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1629178314
PECOS PAC ID: 6204017122
Enrollment ID: I20110225000482

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBhavikaben Babaria
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1912227414
PECOS PAC ID: 1355529363
Enrollment ID: I20110622000225

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMarian Pokuah
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1861651093
PECOS PAC ID: 9234309634
Enrollment ID: I20110822000459

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCandice C Paul
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1972897775
PECOS PAC ID: 9638340235
Enrollment ID: I20110912000055

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRachel N Adams
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1164707642
PECOS PAC ID: 6406021781
Enrollment ID: I20111215000098

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCarolyn M Keresztury
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1033495965
PECOS PAC ID: 7416123245
Enrollment ID: I20111229000083

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMuhammad Hanif
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1487792503
PECOS PAC ID: 6901997030
Enrollment ID: I20120130000258

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDiem N Tran
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1639465578
PECOS PAC ID: 9436316577
Enrollment ID: I20120201000765

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJaclyn Detweiler
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1407125826
PECOS PAC ID: 0941461420
Enrollment ID: I20120410000188

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSamer Badr
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1215191556
PECOS PAC ID: 0749441129
Enrollment ID: I20120411000536

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSherry Kamal Hanna
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1770750655
PECOS PAC ID: 6709047038
Enrollment ID: I20120413000448

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAnthony Angelow
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1922381375
PECOS PAC ID: 3678735412
Enrollment ID: I20120424000452

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameChelo M Sipaco Ong
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1861647166
PECOS PAC ID: 5890958367
Enrollment ID: I20120521000012

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameEbele Edith Ufondu
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1003979048
PECOS PAC ID: 4880858356
Enrollment ID: I20120613000253

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRaquel Nahra
Provider TypePractitioner - Infectious Disease
Provider IdentifiersNPI Number: 1306039359
PECOS PAC ID: 3779658455
Enrollment ID: I20120619000310

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAdolfo E Prettelt
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1205989241
PECOS PAC ID: 0749464527
Enrollment ID: I20120626000083

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMichael Stephen Kocinski
Provider TypePractitioner - Osteopathic Manipulative Medicine
Provider IdentifiersNPI Number: 1295798262
PECOS PAC ID: 7113920711
Enrollment ID: I20120627000092

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJenny Melli
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1568690642
PECOS PAC ID: 2264688019
Enrollment ID: I20120809000450

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJennifer R Roszkowski
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1265697528
PECOS PAC ID: 6901052356
Enrollment ID: I20120820000017

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDaniel S Fabius
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1073884680
PECOS PAC ID: 8123275500
Enrollment ID: I20120821000448

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMelissa B Mangold
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1699939561
PECOS PAC ID: 7618155839
Enrollment ID: I20121008000323

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNina Siu
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1699022145
PECOS PAC ID: 1456500149
Enrollment ID: I20121015000128

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCatherine T Maturo
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1326068099
PECOS PAC ID: 5698810612
Enrollment ID: I20121022000008

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameWissam Sabri Zaeeter
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1801191408
PECOS PAC ID: 5092966887
Enrollment ID: I20121102000283

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePatricia L Mazza
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1407149172
PECOS PAC ID: 2769453216
Enrollment ID: I20121119000101

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJoel S Steinberg
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1477650638
PECOS PAC ID: 5092717900
Enrollment ID: I20121213000148

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameIbironke A Macaulay
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1235426503
PECOS PAC ID: 9739343336
Enrollment ID: I20130107000073

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameIris Shihong
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1295979029
PECOS PAC ID: 7719150408
Enrollment ID: I20130131000069

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameWei L Chen
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1790018869
PECOS PAC ID: 6800032715
Enrollment ID: I20130422000012

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameStephanie Whalen
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1619265279
PECOS PAC ID: 8123260205
Enrollment ID: I20130820000808

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameLisa Williams
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1942573795
PECOS PAC ID: 0547424491
Enrollment ID: I20130824000152

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSammar Rasheed
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1669718631
PECOS PAC ID: 6709020563
Enrollment ID: I20130917000287

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSameer Poddar
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1740591247
PECOS PAC ID: 8628212982
Enrollment ID: I20130926000649

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCindy J Hogan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1538410527
PECOS PAC ID: 7810132008
Enrollment ID: I20131014000308

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCharlotte S Nussbaum
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1841425196
PECOS PAC ID: 8426283938
Enrollment ID: I20131108000038

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameVincent Jay Vanston
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1851385744
PECOS PAC ID: 3274545363
Enrollment ID: I20131115000425

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJean B Gue
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1831434257
PECOS PAC ID: 2264668250
Enrollment ID: I20131127000008

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSadaf Ausaf
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1548573439
PECOS PAC ID: 0648408070
Enrollment ID: I20140110000955

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameLin Zheng
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1598095747
PECOS PAC ID: 1759573439
Enrollment ID: I20140113001055

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJill K Rogers
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1093065922
PECOS PAC ID: 2668603606
Enrollment ID: I20140315000209

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRachel Popick
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1053653543
PECOS PAC ID: 9032341193
Enrollment ID: I20140404000235

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMuhammad S Uppal
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1144589730
PECOS PAC ID: 1254589021
Enrollment ID: I20140410001055

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKatarzyna A Andruchow
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1710304100
PECOS PAC ID: 8325261514
Enrollment ID: I20140515000395

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKrista D Lecompte
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1326479536
PECOS PAC ID: 5991928533
Enrollment ID: I20140528002099

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDana D Byrne
Provider TypePractitioner - Infectious Disease
Provider IdentifiersNPI Number: 1598927121
PECOS PAC ID: 0547402927
Enrollment ID: I20140618001293

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSatyam A Shah
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1265691471
PECOS PAC ID: 9436212677
Enrollment ID: I20140718000774

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKevin R Emmons
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1356752562
PECOS PAC ID: 0143447573
Enrollment ID: I20140808000761

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAmanda A Valvano
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1023249331
PECOS PAC ID: 2961620711
Enrollment ID: I20140820001857

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameFern Elyse Kopp Mulberg
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1699077909
PECOS PAC ID: 8628206075
Enrollment ID: I20140904000975

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBibbin P George
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1780971028
PECOS PAC ID: 5092934489
Enrollment ID: I20140917001275

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameFarhan A Malik
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1437572468
PECOS PAC ID: 5294955290
Enrollment ID: I20140925000389

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAfaf Anter
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1003237769
PECOS PAC ID: 8426278276
Enrollment ID: I20140930001555

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameLorraine O Salieb
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1881986263
PECOS PAC ID: 0244452613
Enrollment ID: I20141119002337

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJasneet Gandehok
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1922307248
PECOS PAC ID: 7517189871
Enrollment ID: I20141121000443

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMyanh Thi Nguyen
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1235495276
PECOS PAC ID: 5193972461
Enrollment ID: I20141216001719

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDoreen Nestler
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1548604945
PECOS PAC ID: 6305162082
Enrollment ID: I20150225000626

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJennifer Holian
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1366796799
PECOS PAC ID: 3274786496
Enrollment ID: I20150317000037

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDiana Kolman-taddeo
Provider TypePractitioner - Pulmonary Disease
Provider IdentifiersNPI Number: 1982866646
PECOS PAC ID: 7214102821
Enrollment ID: I20150506000126

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBryan Todd Fromkin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1124412598
PECOS PAC ID: 8224357470
Enrollment ID: I20150511000249

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameVivek S Ramanathan
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1427353630
PECOS PAC ID: 3971775149
Enrollment ID: I20150629001267

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSamuel Solomon Hardy
Provider TypePractitioner - Hospice/palliative Care
Provider IdentifiersNPI Number: 1851714141
PECOS PAC ID: 9335452259
Enrollment ID: I20150722003504

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNicole Terrigno
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1679985097
PECOS PAC ID: 6406169127
Enrollment ID: I20150723007669

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMichael Edwards Taylor
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1245632058
PECOS PAC ID: 5395058028
Enrollment ID: I20150723008052

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJinyu Lu
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1679834428
PECOS PAC ID: 8325352586
Enrollment ID: I20150731015256

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameZoheb Fazal
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1538578489
PECOS PAC ID: 0941515175
Enrollment ID: I20150818004476

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSaurabh Mehta
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1942563994
PECOS PAC ID: 6204142078
Enrollment ID: I20150825004727

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKendall M Blair
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1508116773
PECOS PAC ID: 7416263900
Enrollment ID: I20150828001072

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNathaniel F Gabriel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1104217488
PECOS PAC ID: 6204142201
Enrollment ID: I20150908000940

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameOkebugwu Kamalu
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1053720847
PECOS PAC ID: 5991014847
Enrollment ID: I20151016000671

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameUzoma Chinyere Oranu
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1780943589
PECOS PAC ID: 4981913548
Enrollment ID: I20151021001932

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCorina Pereira Meade
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962881300
PECOS PAC ID: 6800105420
Enrollment ID: I20151022001156

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMichelle Minock
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1730573825
PECOS PAC ID: 2365751518
Enrollment ID: I20151029000395

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAllen Clowers
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1386624427
PECOS PAC ID: 0941309256
Enrollment ID: I20160111000154

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAnne Kim
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1003287236
PECOS PAC ID: 5597069187
Enrollment ID: I20160202000502

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGina L Christaldi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1083084727
PECOS PAC ID: 9335446335
Enrollment ID: I20160317002009

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameShilpa Chaudhari
Provider TypePractitioner - Infectious Disease
Provider IdentifiersNPI Number: 1083952493
PECOS PAC ID: 4981921624
Enrollment ID: I20160324000228

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGlenys Z Merette De La Rosa
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1770802944
PECOS PAC ID: 6800052895
Enrollment ID: I20160406000502

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAnupama Voodarla
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1588857320
PECOS PAC ID: 6608947510
Enrollment ID: I20160429000029

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBradley Foster Bender
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1013356237
PECOS PAC ID: 0446540561
Enrollment ID: I20160602000493

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMaher Al Safadi
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1083053235
PECOS PAC ID: 2769788439
Enrollment ID: I20160613002248

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJennifer B Entrekin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1619369378
PECOS PAC ID: 2769701259
Enrollment ID: I20160628002546

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCharlton Olayemi
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1831580497
PECOS PAC ID: 5799079919
Enrollment ID: I20160811000844

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNavjot Singh Grewal
Provider TypePractitioner - Sleep Medicine
Provider IdentifiersNPI Number: 1245646231
PECOS PAC ID: 5395039358
Enrollment ID: I20160815000406

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDaniel Robert Foxx
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1487001558
PECOS PAC ID: 3971898685
Enrollment ID: I20160819001126

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAlexandra Lane
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1134483076
PECOS PAC ID: 0446571616
Enrollment ID: I20160823000151

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKrysta Marie Contino
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1740695782
PECOS PAC ID: 9133414527
Enrollment ID: I20160824001965

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameEffat Jabeen
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1871901082
PECOS PAC ID: 6002101037
Enrollment ID: I20160830000079

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameLara Roseman
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1225484702
PECOS PAC ID: 1254627292
Enrollment ID: I20160831000817

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAkshar Patel
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1548678246
PECOS PAC ID: 2567758121
Enrollment ID: I20160907002309

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSriharshan Reddy
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1972948016
PECOS PAC ID: 9133415631
Enrollment ID: I20160909000723

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCamille Green
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1811293921
PECOS PAC ID: 6406142777
Enrollment ID: I20160913001332

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAlyson M Stahler
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1124365333
PECOS PAC ID: 7517111784
Enrollment ID: I20160916002092

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMonika Bhalla
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1114368974
PECOS PAC ID: 6507153541
Enrollment ID: I20160920000638

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMonil Patel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1649619826
PECOS PAC ID: 2769779719
Enrollment ID: I20160920000718

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKajal Patel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1881021509
PECOS PAC ID: 7618264680
Enrollment ID: I20160920001393

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameFaith Marie Young
Provider TypePractitioner - Hematology/oncology
Provider IdentifiersNPI Number: 1760400451
PECOS PAC ID: 3274597380
Enrollment ID: I20161018002010

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRajiv Arapurakal
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1437568318
PECOS PAC ID: 2769760016
Enrollment ID: I20161020002346

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAmber Majid
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1912344078
PECOS PAC ID: 3072892454
Enrollment ID: I20161108002038

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGinalyn A Poblete
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1356673511
PECOS PAC ID: 3870873250
Enrollment ID: I20161130001085

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameColleen M Di Luigi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1649724816
PECOS PAC ID: 3476833575
Enrollment ID: I20161207000944

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameTheresa M Pileggi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1366713323
PECOS PAC ID: 5496062408
Enrollment ID: I20161214000292

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRachel Degtyarev
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1205371770
PECOS PAC ID: 2163707001
Enrollment ID: I20170316000839

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSaiham Shahabuddin
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1295078145
PECOS PAC ID: 0345520961
Enrollment ID: I20170317000475

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMegan Cote
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1437696655
PECOS PAC ID: 9436435559
Enrollment ID: I20170404000584

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDawn Specht
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1497299242
PECOS PAC ID: 2668758822
Enrollment ID: I20170425000040

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJaneen Burns
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1497296925
PECOS PAC ID: 4183901051
Enrollment ID: I20170502000153

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAfsheen Masood
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1548666373
PECOS PAC ID: 1658658984
Enrollment ID: I20170515001053

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJohn Mcgeehan
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1366426181
PECOS PAC ID: 5698661759
Enrollment ID: I20170608000486

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSarah Farrell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1811933559
PECOS PAC ID: 4789680075
Enrollment ID: I20170608002049

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameReena Pramood
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1649431263
PECOS PAC ID: 9830384940
Enrollment ID: I20170718000682

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAmanda Davis
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1306374426
PECOS PAC ID: 2961773890
Enrollment ID: I20170810001289

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAgnes Adarkwa
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1982012639
PECOS PAC ID: 3678844560
Enrollment ID: I20170811000095

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameIris Hagans
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1669888129
PECOS PAC ID: 1153693957
Enrollment ID: I20170814001932

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameLu Fan
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1548687742
PECOS PAC ID: 4880966654
Enrollment ID: I20170815001436

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGrace H Lee
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1245494210
PECOS PAC ID: 3476825258
Enrollment ID: I20170815002177

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameWilliam E Oberdorf
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1437569431
PECOS PAC ID: 2264705045
Enrollment ID: I20170829003772

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCecilia Fix
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1679991806
PECOS PAC ID: 5092088773
Enrollment ID: I20170830003752

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCecile King
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1114361748
PECOS PAC ID: 7517180359
Enrollment ID: I20170901000069

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameLawrence Matthews
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1407264294
PECOS PAC ID: 3678847183
Enrollment ID: I20170922000096

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAndre C Gabriel
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1043630833
PECOS PAC ID: 4688949464
Enrollment ID: I20171004001247

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAndrew James Moore
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1144667247
PECOS PAC ID: 7911200670
Enrollment ID: I20171011000374

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameVinay Motu Palli
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1558776336
PECOS PAC ID: 8628344801
Enrollment ID: I20171017001628

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameHimabindu M Lanka
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1780964825
PECOS PAC ID: 9234447145
Enrollment ID: I20171019002796

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAshok R. Mandala
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1629275342
PECOS PAC ID: 0840350328
Enrollment ID: I20171023000392

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMirette Salib
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1124435698
PECOS PAC ID: 4082970363
Enrollment ID: I20171102003442

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePriten C Patel
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1831530237
PECOS PAC ID: 5294002861
Enrollment ID: I20171204000226

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKathryn Battle
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1306384409
PECOS PAC ID: 5395716294
Enrollment ID: I20171219000084

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAshley V Weinmann
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1700215332
PECOS PAC ID: 4486884954
Enrollment ID: I20171219001368

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAnastasia Jean Bullock
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1619480795
PECOS PAC ID: 4688932437
Enrollment ID: I20171227002216

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKimberly Ann Leotta
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1336443324
PECOS PAC ID: 1456535459
Enrollment ID: I20180126000410

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJayme Robin Morris
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1396049003
PECOS PAC ID: 7012211683
Enrollment ID: I20180221001028

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKasey N Mathews
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1689048316
PECOS PAC ID: 6901107523
Enrollment ID: I20180320001295

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKambiz Reza Butt
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1679758437
PECOS PAC ID: 9032277868
Enrollment ID: I20180328001866

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMuhammad A Pervez
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1245578632
PECOS PAC ID: 5597907055
Enrollment ID: I20180413001901

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameTara Marie Mcgrory
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1326540733
PECOS PAC ID: 0042575078
Enrollment ID: I20180522002937

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKenneth Chan Lee So
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1528448461
PECOS PAC ID: 0345597068
Enrollment ID: I20180725003242

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDaniel Scott Wilen
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1154702363
PECOS PAC ID: 6305193046
Enrollment ID: I20180726000263

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNicholas Calvin Calder
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1477937217
PECOS PAC ID: 5991052649
Enrollment ID: I20180726000444

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJames Liu
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1013391457
PECOS PAC ID: 8729336961
Enrollment ID: I20180806000869

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAditya Bakhshi
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1538544366
PECOS PAC ID: 6507115862
Enrollment ID: I20180820001589

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameEmily Melissa Sussman
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1407239064
PECOS PAC ID: 7315296613
Enrollment ID: I20180820003467

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDana A Albinson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1790180834
PECOS PAC ID: 0840512646
Enrollment ID: I20180821003400

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRachel J Masel-miller
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1659764025
PECOS PAC ID: 8022393560
Enrollment ID: I20180822002086

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRachel Susan Nash
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1679983951
PECOS PAC ID: 5193944569
Enrollment ID: I20180822002405

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAdip Pillai
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1841685088
PECOS PAC ID: 7315296142
Enrollment ID: I20180828000111

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJane Wu
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1326585654
PECOS PAC ID: 2365727450
Enrollment ID: I20180830003010

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameParminder Mann
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1811481609
PECOS PAC ID: 9739439258
Enrollment ID: I20180904003430

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameChristopher Jude Bazergui
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1710365432
PECOS PAC ID: 2668723347
Enrollment ID: I20180919001019

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKaren Heard Cushing
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1720421217
PECOS PAC ID: 4183859424
Enrollment ID: I20181106000787

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameYasmin Khawja
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1407116452
PECOS PAC ID: 7416173208
Enrollment ID: I20181106001811

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameStephanie M Burns
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1437520319
PECOS PAC ID: 5698029825
Enrollment ID: I20181107000414

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameOla Ihuoma Ibekwe
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1386029080
PECOS PAC ID: 8325392145
Enrollment ID: I20181114002298

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameVadim Divilov
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1841678422
PECOS PAC ID: 1759630577
Enrollment ID: I20181231000122

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMelissa C Hetzell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1942778592
PECOS PAC ID: 3476890138
Enrollment ID: I20190204001255

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKatherine Rose Cosimi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1851870885
PECOS PAC ID: 3375882947
Enrollment ID: I20190226000505

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNavjot Jain
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1609284397
PECOS PAC ID: 4385930676
Enrollment ID: I20190226002758

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNovia Singh
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1356738835
PECOS PAC ID: 5698014165
Enrollment ID: I20190227001627

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAung M Aye
Provider TypePractitioner - Rheumatology
Provider IdentifiersNPI Number: 1609297522
PECOS PAC ID: 5597071175
Enrollment ID: I20190429001118

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAdam Saalfelder
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871052910
PECOS PAC ID: 8325372782
Enrollment ID: I20190619001275

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDonna Ward
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1023262128
PECOS PAC ID: 0345390316
Enrollment ID: I20190625003509

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNeena Rachel Winter
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1619113404
PECOS PAC ID: 3375731763
Enrollment ID: I20190627001823

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMegan Manno
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1831553072
PECOS PAC ID: 3577897230
Enrollment ID: I20190628002160

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAkhil Kumar
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1598110199
PECOS PAC ID: 5698001279
Enrollment ID: I20190722000178

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRoozbeh Ghavami
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1730541103
PECOS PAC ID: 0143556829
Enrollment ID: I20190802000207

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePrateek Luthra
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1609289404
PECOS PAC ID: 3274860796
Enrollment ID: I20190807000224

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCynthia L Glickman
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1275982258
PECOS PAC ID: 5799012167
Enrollment ID: I20190807002589

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePhilip Joseph Fizur
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1730743600
PECOS PAC ID: 1951638212
Enrollment ID: I20190808002343

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameTyler Webb Mcmillan
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1407202492
PECOS PAC ID: 2668763723
Enrollment ID: I20190809000483

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSunil Ramaswamy
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1376906347
PECOS PAC ID: 3577857598
Enrollment ID: I20190809001826

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNiharika Sanjeev Sathe
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1255780599
PECOS PAC ID: 6002143849
Enrollment ID: I20190816000149

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameLaurie Charles
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1154678456
PECOS PAC ID: 4587958863
Enrollment ID: I20190816003043

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDanielle Chimento
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1528412285
PECOS PAC ID: 7214265057
Enrollment ID: I20190819000629

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameHeaton David Kath
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1295184463
PECOS PAC ID: 1850629163
Enrollment ID: I20190824000461

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNatallia Breibart
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1487009114
PECOS PAC ID: 9436487741
Enrollment ID: I20190826000005

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePaul I Cowen
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1619358892
PECOS PAC ID: 4385921931
Enrollment ID: I20190826000037

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDominic A De Angelo
Provider TypePractitioner - Critical Care (intensivists)
Provider IdentifiersNPI Number: 1730549205
PECOS PAC ID: 5991080343
Enrollment ID: I20190826000058

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKathryn Lien Haroldson
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1831544493
PECOS PAC ID: 7315237997
Enrollment ID: I20190828000911

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameEugenia Wede Collins
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1124531900
PECOS PAC ID: 0941563001
Enrollment ID: I20190905000609

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMelissa Pluguez Moldavskiy
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1659858900
PECOS PAC ID: 7911236591
Enrollment ID: I20190906001286

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameIsha Marina Di Bartolo
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1205298940
PECOS PAC ID: 1355670738
Enrollment ID: I20190910002767

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMai Abd Alqader
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1487001848
PECOS PAC ID: 0749556959
Enrollment ID: I20190911000298

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCharles Jiao
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1023404126
PECOS PAC ID: 1759679715
Enrollment ID: I20190923001576

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJillian Ashley Norton Jones
Provider TypePractitioner - Addiction Medicine
Provider IdentifiersNPI Number: 1669887493
PECOS PAC ID: 6305118092
Enrollment ID: I20191003000468

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameShannon Hope Harrington
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1306290978
PECOS PAC ID: 2567793847
Enrollment ID: I20191017002242

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameFranziska F Jovin
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1649243247
PECOS PAC ID: 6800920315
Enrollment ID: I20191030001576

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJasmeet Kaur Mehta
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1881048676
PECOS PAC ID: 5890027502
Enrollment ID: I20191030001760

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameElizbeth Leilani Lee
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1023261112
PECOS PAC ID: 8022132554
Enrollment ID: I20200113000775

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameStephanie Bayruns
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1992151732
PECOS PAC ID: 2163712530
Enrollment ID: I20200213001629

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNaitik Patel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1255771606
PECOS PAC ID: 1850674490
Enrollment ID: I20200220000585

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKevin D Mello
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1477866150
PECOS PAC ID: 9234372103
Enrollment ID: I20200305002034

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameLeena Mathew
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1629319777
PECOS PAC ID: 8426291220
Enrollment ID: I20200323000386

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNicole Sara Speechley
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1710510201
PECOS PAC ID: 3375972953
Enrollment ID: I20200402000635

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJennifer L Davoli
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1326682311
PECOS PAC ID: 4082044110
Enrollment ID: I20200414000025

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMaria Lakernick
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1891324380
PECOS PAC ID: 5799116596
Enrollment ID: I20200512000440

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCaitlin Mcmahon
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679100028
PECOS PAC ID: 4486076536
Enrollment ID: I20200619000255

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSuzette Melanie Washington
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1427670272
PECOS PAC ID: 7618399551
Enrollment ID: I20200622002003

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameChelo Bautista
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1689205411
PECOS PAC ID: 2365864824
Enrollment ID: I20200630000578

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameFahim Hasani
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1891221578
PECOS PAC ID: 9739502568
Enrollment ID: I20200713000282

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAyobamidele Saheed Balogun
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1457871832
PECOS PAC ID: 8527481332
Enrollment ID: I20200713002686

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMiguel Deleon
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1306376264
PECOS PAC ID: 1456774041
Enrollment ID: I20200715001733

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAndrew Gregory Ajemian
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1255851317
PECOS PAC ID: 9436573029
Enrollment ID: I20200715001849

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAlexandra Vrancik
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1740702083
PECOS PAC ID: 8426472531
Enrollment ID: I20200722002641

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMarlena Klein
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1457871063
PECOS PAC ID: 2264856087
Enrollment ID: I20200727000057

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameThomas John Wall
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1952822595
PECOS PAC ID: 7517381346
Enrollment ID: I20200727000426

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameVede James Ramdass
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1780107482
PECOS PAC ID: 0648696401
Enrollment ID: I20200811003870

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKristen Marotta
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1881125698
PECOS PAC ID: 4587902408
Enrollment ID: I20200812000315

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKristen Patterson
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1659812642
PECOS PAC ID: 9830515477
Enrollment ID: I20200813001890

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSamantha Pop
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1801326400
PECOS PAC ID: 6002188299
Enrollment ID: I20200817000024

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAmy Scholl
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1487184503
PECOS PAC ID: 6507127727
Enrollment ID: I20200902000197

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameVaishali Dinesh Patel
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1255854717
PECOS PAC ID: 1052739000
Enrollment ID: I20200908003154

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSean Matchett
Provider TypePractitioner - Osteopathic Manipulative Medicine
Provider IdentifiersNPI Number: 1295261287
PECOS PAC ID: 1254695729
Enrollment ID: I20200909000576

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAshley Michael
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1174917140
PECOS PAC ID: 2567880792
Enrollment ID: I20200921000081

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePratik S Shah
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1033626403
PECOS PAC ID: 1052730157
Enrollment ID: I20200923000379

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCaitlin Lagrotte
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1164046462
PECOS PAC ID: 8325468192
Enrollment ID: I20201015002853

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJibran Saeed Malik
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1902337496
PECOS PAC ID: 9638440720
Enrollment ID: I20201104000009

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGladwin Kemunto Omare
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1609481308
PECOS PAC ID: 8123439130
Enrollment ID: I20201124000419

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAlfred Samura
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1316470958
PECOS PAC ID: 7911318795
Enrollment ID: I20201130002037

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameWilliam Michael Skelton
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1285235077
PECOS PAC ID: 8022429695
Enrollment ID: I20201203000578

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePranav V Patel
Provider TypePractitioner - Cardiovascular Disease (cardiology)
Provider IdentifiersNPI Number: 1093177594
PECOS PAC ID: 2466750997
Enrollment ID: I20201209000043

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSirly Jeevan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962636779
PECOS PAC ID: 0446305759
Enrollment ID: I20201209000861

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMichael Gross
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1396037313
PECOS PAC ID: 6507005444
Enrollment ID: I20201211000420

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCarlisa Brown
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1184256182
PECOS PAC ID: 4587091988
Enrollment ID: I20210111000876

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRachel Teresa Digalbo
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1982200010
PECOS PAC ID: 7911310859
Enrollment ID: I20210113001818

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDaisy Velez
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1417414400
PECOS PAC ID: 2365855020
Enrollment ID: I20210119002692

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameHammad Malik
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013506583
PECOS PAC ID: 6305251828
Enrollment ID: I20210216000883

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAmna Shaikh
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1558784371
PECOS PAC ID: 3577871987
Enrollment ID: I20210413000360

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameZachary Klock
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1639602576
PECOS PAC ID: 0840569893
Enrollment ID: I20210709002874

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameTammy T Turner
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1780188417
PECOS PAC ID: 0941549422
Enrollment ID: I20210712001427

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameChristopher David Perez
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1184104911
PECOS PAC ID: 8820491293
Enrollment ID: I20210722001273

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSameena Khan
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1356845507
PECOS PAC ID: 6608279005
Enrollment ID: I20210722002442

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNika Filatova
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1437644176
PECOS PAC ID: 0446653729
Enrollment ID: I20210723001863

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGopi Faldu
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1164926697
PECOS PAC ID: 9234461799
Enrollment ID: I20210727000565

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameParth Shah
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1093212144
PECOS PAC ID: 9032461843
Enrollment ID: I20210727000879

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJoseph Arthur Grogg
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1942797857
PECOS PAC ID: 1658626288
Enrollment ID: I20210729002449

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGregory Hilditch
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1033697834
PECOS PAC ID: 8921401720
Enrollment ID: I20210729004060

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameIan Gleaner
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1598257354
PECOS PAC ID: 9537414537
Enrollment ID: I20210803000105

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameEmma White
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1457889529
PECOS PAC ID: 1254609092
Enrollment ID: I20210804001650

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNosisa Siziba
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1851965214
PECOS PAC ID: 4688078934
Enrollment ID: I20210809001195

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMatthew Thomas Springer
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1144727561
PECOS PAC ID: 9931504776
Enrollment ID: I20210817003499

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJustin K Johnson
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1962822593
PECOS PAC ID: 6608170683
Enrollment ID: I20210818001963

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameYogita Sharma
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1316366826
PECOS PAC ID: 0244515955
Enrollment ID: I20210824000745

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDaniel Ricketti
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1538653548
PECOS PAC ID: 4183029358
Enrollment ID: I20210826000430

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGabrielle Hassinger
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1659866523
PECOS PAC ID: 0446655518
Enrollment ID: I20210827001154

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameManav Bandlamudi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1538656616
PECOS PAC ID: 9133525652
Enrollment ID: I20210909000698

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJessica Shoukry
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1205338415
PECOS PAC ID: 2769739689
Enrollment ID: I20210915002798

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameFawaz Anwar
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1942793187
PECOS PAC ID: 9335546431
Enrollment ID: I20210915003577

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSe-eun Lee
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1932302379
PECOS PAC ID: 0648465450
Enrollment ID: I20210916001555

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDana Rosario
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871171900
PECOS PAC ID: 0941608186
Enrollment ID: I20211001001949

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBruce Smith
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1952668824
PECOS PAC ID: 5395058929
Enrollment ID: I20211018000007

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAlexa Michelle Hays
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1801466297
PECOS PAC ID: 2163810094
Enrollment ID: I20211027000181

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNikhil Bhalla
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1669979811
PECOS PAC ID: 3870981541
Enrollment ID: I20211029000172

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJoanitta Manu
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1437653664
PECOS PAC ID: 8123417094
Enrollment ID: I20211115001955

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameHan Le
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1437679800
PECOS PAC ID: 5496144263
Enrollment ID: I20211117000005

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRhea Farquhar
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1427548841
PECOS PAC ID: 5698165769
Enrollment ID: I20211203000597

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameFrancis Oswald
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1881353449
PECOS PAC ID: 4688066269
Enrollment ID: I20220111000433

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameChand C Marvania
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1326500372
PECOS PAC ID: 2062804511
Enrollment ID: I20220113001738

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAngie Treacy
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1548778483
PECOS PAC ID: 2668736729
Enrollment ID: I20220323000374

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJennifer Hampton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1700471562
PECOS PAC ID: 4486041233
Enrollment ID: I20220425002059

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAyo Oguntoye
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1922530880
PECOS PAC ID: 1951798891
Enrollment ID: I20220426000668

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNicholas R Young
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1396270393
PECOS PAC ID: 9032488820
Enrollment ID: I20220426001294

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAnthony Rizk Tanious
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1780146647
PECOS PAC ID: 3173901568
Enrollment ID: I20220525000972

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBethany Milano
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1063097897
PECOS PAC ID: 6800274150
Enrollment ID: I20220527001989

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNicole Delcore
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1225793276
PECOS PAC ID: 6204214240
Enrollment ID: I20220603001991

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameIvan Richard
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1164783205
PECOS PAC ID: 8628320348
Enrollment ID: I20220715002262

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAli Haydar
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1720648223
PECOS PAC ID: 1658607189
Enrollment ID: I20220728002257

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameGabriela J Contino
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1689170508
PECOS PAC ID: 1759625395
Enrollment ID: I20220803001383

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJaanki Dave
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1558824789
PECOS PAC ID: 4587046750
Enrollment ID: I20220804001078

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDhruv Patel
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1194285981
PECOS PAC ID: 4486036407
Enrollment ID: I20220808000135

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameChristopher Daniel Fernandez
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1164083002
PECOS PAC ID: 7012390974
Enrollment ID: I20220810002784

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMary Kraemer
Provider TypePractitioner - Hospice/palliative Care
Provider IdentifiersNPI Number: 1568450468
PECOS PAC ID: 7416939855
Enrollment ID: I20220810003220

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameOlena Fleury
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1164985032
PECOS PAC ID: 8224411020
Enrollment ID: I20220811000960

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePartia Patel
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1568023034
PECOS PAC ID: 3375926058
Enrollment ID: I20220812001013

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameVictor Pomary
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1902469141
PECOS PAC ID: 8123401700
Enrollment ID: I20220815001256

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameZiqian Wang
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1053971507
PECOS PAC ID: 0840673448
Enrollment ID: I20220815001798

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRichard T Wolfe
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1275190571
PECOS PAC ID: 2365774601
Enrollment ID: I20220815002027

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSamuel Masur
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1144712878
PECOS PAC ID: 5496000507
Enrollment ID: I20220901000447

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAngela K Chang
Provider TypePractitioner - Hospice/palliative Care
Provider IdentifiersNPI Number: 1336632181
PECOS PAC ID: 1153678628
Enrollment ID: I20220908002984

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSandhya Ashokkumar
Provider TypePractitioner - Emergency Medicine
Provider IdentifiersNPI Number: 1457913402
PECOS PAC ID: 6406230572
Enrollment ID: I20220908003184

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKatherine Dipastina
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1790344257
PECOS PAC ID: 8426384975
Enrollment ID: I20220920000547

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAlisa Peet
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1023005949
PECOS PAC ID: 0547150575
Enrollment ID: I20221003002251

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJonathan Edelstein
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1932762077
PECOS PAC ID: 6507232857
Enrollment ID: I20221012001280

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameDonald No
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1053730242
PECOS PAC ID: 6103145511
Enrollment ID: I20221017002990

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameLauren M Spaciano
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1184016081
PECOS PAC ID: 9537472238
Enrollment ID: I20221019000583

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameNikia Rahemtulla
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1730630898
PECOS PAC ID: 1456633437
Enrollment ID: I20221031001648

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBali Gupta
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1316409634
PECOS PAC ID: 5890163133
Enrollment ID: I20221117002946

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMonal Patel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1770044463
PECOS PAC ID: 6800264060
Enrollment ID: I20221118000365

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSofia Dar
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1124587993
PECOS PAC ID: 0042544827
Enrollment ID: I20221121000665

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameTiffany Haer
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1235859117
PECOS PAC ID: 3577932128
Enrollment ID: I20221205000037

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBrittany Allison Haage
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1437726940
PECOS PAC ID: 3173994514
Enrollment ID: I20230124000627

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRosemarie E Maitland
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1861100349
PECOS PAC ID: 6608240296
Enrollment ID: I20230322001435

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameStephanie Dianna Tyell Burton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1750094397
PECOS PAC ID: 2365730900
Enrollment ID: I20230629002416

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameIrfan Khan
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1922627280
PECOS PAC ID: 9234598400
Enrollment ID: I20230713001552

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJohn Lapadula
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1811203342
PECOS PAC ID: 0042445405
Enrollment ID: I20230731001130

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameTrishna Acherjee
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1417501669
PECOS PAC ID: 5294116117
Enrollment ID: I20230802003134

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAlan Xing
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1285253815
PECOS PAC ID: 0749602662
Enrollment ID: I20230812000142

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJane Atallah
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1558983189
PECOS PAC ID: 6002279684
Enrollment ID: I20230830000393

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NamePrarthi Patel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1821626409
PECOS PAC ID: 4880057488
Enrollment ID: I20230830001372

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAhmed Naeem
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1922669803
PECOS PAC ID: 5597128991
Enrollment ID: I20230901001272

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameBrisha Best
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1104455542
PECOS PAC ID: 8729405683
Enrollment ID: I20230929001887

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMyriam S Cruz
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1780212480
PECOS PAC ID: 7416302880
Enrollment ID: I20231005001036

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameO'neil Chaudhry
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1699396275
PECOS PAC ID: 4385099613
Enrollment ID: I20231006000569

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAshvin Vijayakumar
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1659782464
PECOS PAC ID: 8921338096
Enrollment ID: I20231017000981

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJulia Zorko
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1598392474
PECOS PAC ID: 0840615936
Enrollment ID: I20231018001399

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAkosua Akyaa Osei Owusu
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1144900465
PECOS PAC ID: 8527414036
Enrollment ID: I20231019001173

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKristianne Amurao
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1225650856
PECOS PAC ID: 7517380397
Enrollment ID: I20231019003622

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameIzaz Kazmi
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1477181634
PECOS PAC ID: 7416303748
Enrollment ID: I20231024000174

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameJessica Pierobon
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1093121618
PECOS PAC ID: 1456578772
Enrollment ID: I20231024003543

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameFendy Md Jn Pierre
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1134501232
PECOS PAC ID: 0446505929
Enrollment ID: I20231026002092

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameHafiz M Hassan Shoukat
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1881128411
PECOS PAC ID: 4385060342
Enrollment ID: I20231026002382

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameHely Shah
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1346744604
PECOS PAC ID: 5991055352
Enrollment ID: I20231026002680

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameStephanie Mangwi Ndifor
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1720615750
PECOS PAC ID: 0840646899
Enrollment ID: I20231026002724

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameTirth S Talati
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1225665748
PECOS PAC ID: 4587010285
Enrollment ID: I20231101002604

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameRyan Liu
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1730702143
PECOS PAC ID: 4880015510
Enrollment ID: I20231102003258

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSabrina R Gordon
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1861020125
PECOS PAC ID: 8820445034
Enrollment ID: I20231109002085

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameSarah R Fishman
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1417737677
PECOS PAC ID: 9133576085
Enrollment ID: I20231114002680

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameKa Yi Li
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1326508680
PECOS PAC ID: 6507192481
Enrollment ID: I20231208002259

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameZachariah Fishoff
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1366957102
PECOS PAC ID: 8426318940
Enrollment ID: I20231212001188

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameAdriana Marciales
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1194141663
PECOS PAC ID: 2961706312
Enrollment ID: I20231215001237

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameStephnie Brown
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1922738236
PECOS PAC ID: 6800253998
Enrollment ID: I20231222002358

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMichelle Paul
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1952024838
PECOS PAC ID: 1254709025
Enrollment ID: I20231227002065

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameHeather J Kagan
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1720576580
PECOS PAC ID: 3274882014
Enrollment ID: I20240117002773

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameMichael Cooper
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1700266939
PECOS PAC ID: 5698005221
Enrollment ID: I20240216002143

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameCorey Doremus
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1851154264
PECOS PAC ID: 7618311424
Enrollment ID: I20240220004716

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

Provider NameTariq Halasa
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1043754039
PECOS PAC ID: 8729482757
Enrollment ID: I20240307002912

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more Medical News

› Verified 6 days ago

News Archive

Icagen, Pfizer select novel compound for further clinical development in Nav1.7 program

Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.

The Medical College of Wisconsin licenses novel molecular imaging technology to GE Healthcare

A novel molecular imaging technology aimed at rapid diagnosis of cell death in organs such as the brain and heart has been licensed by The Medical College of Wisconsin to GE Healthcare. Under the license GE will further evaluate and develop the technology and will have an option to commercialize the technology. The technology, using imaging probes with a radiopharmaceutical compound, was invented by Ming Zhao, Ph.D., assistant professor of biophysics.

Researchers generate stable cartilage tissue from adult mesenchymal stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Stark introduces universal health insurance bill

House Ways and Means Health Subcommittee Chair Pete Stark (D-Calif.) on Thursday introduced a bill that would seek to provide health insurance to all U.S. residents through Medicare and employer-sponsored coverage, the Oakland Tribune reports.

Read more News

› Verified 6 days ago


Internal Medicine in Camden, NJ

Cooper Physician Offices Pa
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3 Cooper Plz, Suite 215, Camden, NJ 08103
Phone: 856-342-2439    Fax: 856-966-0735
Ololmc Internal Medicine Hospitalists
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1600 Haddon Ave, Internal Medicine, Camden, NJ 08103
Phone: 856-757-3500    
Camcare Health Corporation
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 813 Ferry Ave, Camden, NJ 08104
Phone: 856-602-4012    
Northeast Pain Management
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1 Market St. #1c, Camden, NJ 08102
Phone: 973-558-2732    
Cooper Family Medicine
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3156 River Rd, Camden, NJ 08105
Phone: 856-963-0126    Fax: 856-365-0279
Project H.o.p.e., Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1514 Federal St, Camden, NJ 08105
Phone: 856-541-6092    Fax: 856-541-6097
Project H.o.p.e., Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 510 Liberty St, Camden, NJ 08104
Phone: 856-541-6092    Fax: 856-541-6097

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.